CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Jiangxi Sanxin Medtec Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Jiangxi Sanxin Medtec Co Ltd
No. 999
Fushan Avenue, Xiaolan Industrial Park
Phone: +86 79185950380p:+86 79185950380 NANCHANG, JGX  330200  China Ticker: 300453300453

Business Summary
Jiangxi Sanxin Medtec Co Ltd is a China-based company mainly engaged in the research and development, manufacturing, sales and service of medical devices. The Company's main products include blood purification, infusion, cardiothoracic surgery and diabetes treatment devices, early and mid-stage kidney disease intervention and treatment devices, and vascular intervention devices. The Company's core business is blood purification products, which are used in blood purification treatment for end-stage renal disease (uremia), acute and chronic renal failure, and drug or other substance poisoning. The Company mainly conducts its business in the domestic and foreign markets.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202412/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board YixingPeng 65
President, Director ZhipingMao 49 4/13/2023
Vice Chairman of the Board FenglianLei 61 1/1/2020
9 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,927 (As of 12/31/2023)
Outstanding Shares: 522,397,525 (As of 11/1/2024)
Shareholders: 19,028
Stock Exchange: SHE
Fax Number: +86 79185950380


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, January 30, 2025